Search

Long-term results of incus vibroplasty in patients with moderate-to-severe sensorineural hearing loss

The Vibrant Soundbridge (VSB) middle ear implant is now a well-accepted and widely utilised treatment option for patients with sensorineural hearing loss unable to use standard hearing aids. However, as a relatively recent addition to the portfolio of implants available...

Neuromodulation in drug resistant epilepsy

Treatment of epilepsy can be considered generally as medical or surgical. Anti-epileptic drugs achieve a five-year seizure freedom in 54-70% patients. It is estimated that 50-90% of patients with drug-refractory epilepsy may not be candidates for resective surgery. For example,...

Hidden disabilities and cochlear implantation under 12 months of age

There has been a global shift to providing children with severe-profound deafness cochlear implants (CIs) before they are 12 months old. Early intervention is critical and one of the overriding factors in successful outcomes for children with CIs. Early implantation...

Is it beneficial for children to undergo bilateral cochlear implantation before 12 months old?

Universal newborn hearing screening has allowed early diagnosis and, subsequently, early intervention in hearing loss. In 2020 the Food and Drug Administration candidacy criteria for cochlear implants (CI) expanded to include profound sensorineural hearing loss (HL) in children as young...